567 related articles for article (PubMed ID: 30707474)
41. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in
Adriaanse FRS; Schneider P; Arentsen-Peters STCJM; Fonseca AMND; Stutterheim J; Pieters R; Zwaan CM; Stam RW
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892207
[TBL] [Abstract][Full Text] [Related]
42. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
[No Abstract] [Full Text] [Related]
43. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
[No Abstract] [Full Text] [Related]
44. Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma.
Schafernak KT; Williams JA; Clyde BI; Marcus C; Decker B; Toydemir RM
Cancer Genet; 2021 Nov; 258-259():23-26. PubMed ID: 34237703
[TBL] [Abstract][Full Text] [Related]
45. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
46. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
[TBL] [Abstract][Full Text] [Related]
47. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.
Fu JF; Liang DC; Shih LY
Am J Clin Pathol; 2007 Jan; 127(1):24-30. PubMed ID: 17145626
[TBL] [Abstract][Full Text] [Related]
48. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract][Full Text] [Related]
49. Analysis of gene rearrangements using a fluorescence in situ hybridization method in Mexican patients with acute lymphoblastic leukemia: experience at a single institution.
Pérez-Vera P; Salas C; Montero-Ruiz O; Frías S; Dehesa G; Jarquín B; Rivera-Luna R
Cancer Genet Cytogenet; 2008 Jul; 184(2):94-8. PubMed ID: 18617057
[TBL] [Abstract][Full Text] [Related]
50. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N
J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736
[TBL] [Abstract][Full Text] [Related]
51. The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
Dai B; Yu H; Ma T; Lei Y; Wang J; Zhang Y; Lu J; Yan H; Jiang L; Chen B
J Mol Diagn; 2021 Nov; 23(11):1478-1490. PubMed ID: 34384895
[TBL] [Abstract][Full Text] [Related]
52. Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group.
Pombo-de-Oliveira MS; Andrade FG;
Arch Med Res; 2016 Nov; 47(8):593-606. PubMed ID: 28476187
[TBL] [Abstract][Full Text] [Related]
53. [Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia].
Kim SR; Kim HJ; Kim SH
Korean J Lab Med; 2009 Oct; 29(5):371-8. PubMed ID: 19893343
[TBL] [Abstract][Full Text] [Related]
54. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
[No Abstract] [Full Text] [Related]
55. Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic Leukemia.
Lentes J; Thomay K; Schneider DT; Bernbeck B; Reinhardt D; Marschalek R; Meyer C; Schlegelberger B; Göhring G
Cytogenet Genome Res; 2016; 150(3-4):281-286. PubMed ID: 28253492
[TBL] [Abstract][Full Text] [Related]
56. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
[TBL] [Abstract][Full Text] [Related]
57. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
[TBL] [Abstract][Full Text] [Related]
58. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
[TBL] [Abstract][Full Text] [Related]
59. Spectra of chromosomal aberrations in 325 leukemia patients and implications for the development of new molecular detection systems.
Choi HJ; Kim HR; Shin MG; Kook H; Kim HJ; Shin JH; Suh SP; Ryang DW
J Korean Med Sci; 2011 Jul; 26(7):886-92. PubMed ID: 21738341
[TBL] [Abstract][Full Text] [Related]
60. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]